| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |